SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-052251
Filing Date
2010-10-27
Accepted
2010-10-27 17:43:35
Documents
1
Period of Report
2010-10-27

Document Format Files

Seq Description Document Type Size
1 rrd289263.html 4  
1 rrd289263.xml 4 4667
  Complete submission text file 0001181431-10-052251.txt   6551
Mailing Address C/O AEGERION PHARMACEUTICALS CENTERPOINTE IV, 1140 ROUTE 22 EAST BRIDGEWATER NJ 08807
Business Address
Beer Marc D (Reporting) CIK: 0001314575 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 101145733

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations